Total population | Without manifest vascular disease | With manifest vascular disease | |
---|---|---|---|
n = 1679 | n = 481 | n = 1124 | |
HR (95% CI) | HR (95% CI) | HR (95% CI) | |
Myocardial infarction | n = 156 | n = 25 | n = 131 |
Model I | 1.16 (0.97–1.39) | 1.27 (0.77–2.09) | 1.21 (1.00–1.48) |
Model II | 1.03 (0.85–1.25) | 1.14 (0.67–1.93) | 1.07 (0.86–1.32) |
Model III | 1.14 (0.94–1.38) | 1.15 (0.68–1.96) | 1.07 (0.86–1.33) |
Stroke | n = 85 | n = 16 | n = 61 |
Model I | 1.02 (0.81–1.30) | 0.93 (0.53–1.62) | 1.03 (0.93–1.15) |
Model II | 0.89 (0.68–1.15) | 0.70 (0.38–1.29) | 0.89 (0.65–1.22) |
Model III | 0.83 (0.64–1.08) | 0.69 (0.37–1.28) | 0.91 (0.66–1.25) |
Cardiovascular events | n = 307 | n = 50 | n = 246 |
Model I | 1.16 (1.02–1.33)* | 1.11 (0.79–1.56) | 1.18 (1.03–1.37)* |
Model II | 1.03 (0.90–1.19) | 0.97 (0.67–1.39) | 1.06 (0.91–1.25) |
Model III | 1.08 (0.94–1.25) | 0.99 (0.68–1.44) | 1.07 (0.91–1.25) |
Vascular mortality | n = 184 | n = 29 | n = 154 |
Model I | 1.36 (1.14–1.62)* | 1.20 (0.77–1.86) | 1.38 (1.14–1.66)* |
Model II | 1.20 (1.00–1.45)* | 1.18 (0.73–1.93) | 1.18 (0.95–1.45) |
Model III | 1.21 (1.01–1.46)* | 1.24 (0.75–2.06) | 1.18 (0.95–1.46) |
All-cause mortality | n = 343 | n = 64 | n = 270 |
Model I | 1.10 (1.06–1.13)* | 1.26 (0.94–1.69) | 1.11 (1.06–1.17)* |
Model II | 1.20 (1.04–1.37)* | 1.06 (0.95–1.18) | 1.20 (1.04–1.37)* |
Model III | 1.26 (1.10–1.45)* | 1.17 (0.83–1.63) | 1.21 (1.03–1.41)* |